S. Korea approves Novavax COVID-19 vaccine
General
14:45 January 12, 2022
Food and Drug Safety Minister Kim Gang-lip announces the permit for the use of U.S.-based biotechnology company Novavax Inc.'s COVID-19 vaccine during a briefing at the agency in Cheongju, around 140 kilometers south of Seoul, on Jan. 12, 2022. The protein-based vaccine, Nuvaxovid, marks the fifth COVID-19 vaccine to get approval for use in South Korea, following the ones by AstraZeneca, Pfizer Inc., Johnson & Johnson and Moderna Inc. (Yonhap)
(END)
General
14:45 January 12, 2022
